We have used antisense phosphorothioate oligonucleotides to define the role played by proliferating cell nuclear antigen (PCNA) in neointimal accumulation of smooth muscle cells in a rat carotid artery injury model. The short-term extraluminal delivery of 250 nmol of antisense oligonucleotides, but not control oligonucleotides, immediately after arterial injury produces a 77% suppression of PCNA mRNA after 24 h and a 52% decrease in the frequency of medial smooth muscle cells expressing PCNA after 72 h. This reduction in PCNA expression is accompanied by a 59% decrease in the frequency of proliferating medial smooth muscle cells at 3 d as measured by BudR staining and an 80% decrease in neointimal accumulation assessed morphometrically at 2 wk. Thus, the expression of PCNA is required for medial smooth muscle cell growth in vivo and for neointimal formation after arterial injury.
M Simons, E R Edelman, R D Rosenberg
Title and authors | Publication | Year |
---|---|---|
The Expanding Role of Alternative Splicing in Vascular Smooth Muscle Cell Plasticity
ID Green, R Liu, JJ Wong |
International journal of molecular sciences | 2021 |
Inhibitory effects of scoparone from chestnut inner shell on platelet‐derived growth factor‐BB‐induced vascular smooth muscle cell migration and vascular neointima hyperplasia
SH Jung, GB Lee, Y Ryu, L Cui, HM Lee, J Kim, B Kim, KJ Won |
Journal of the Science of Food and Agriculture | 2019 |
Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
D Wang, P Uhrin, A Mocan, B Waltenberger, JM Breuss, D Tewari, J Mihaly-Bison, Ł Huminiecki, RR Starzyński, NT Tzvetkov, J Horbańczuk, AG Atanasov |
Biotechnology Advances | 2018 |
Perivascular medical devices and drug delivery systems: Making the right choices
I Mylonaki, É Allémann, F Saucy, JA Haefliger, F Delie, O Jordan |
Biomaterials | 2017 |
Wedelolactone, a plant coumarin, prevents vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia through Akt and AMPK signaling
L Peng, X Huang, X Jin, Z Jing, L Yang, Y Zhou, J Ren, Y Zhao |
Experimental Gerontology | 2017 |
Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells
KP Lee, GW Sudjarwo, SH Jung, D Lee, DY Lee, GB Lee, S Baek, DY Kim, HM Lee, B Kim, SC Kwon, KJ Won |
Atherosclerosis | 2015 |
Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay
WP Bozza, K Yang, J Wang, Z Zhuang |
Analytical Biochemistry | 2012 |
Review: Stem Cells and Gene Therapy
FQ Alenzi, M Lotfy, WG Tamimi, RK Wyse |
Laboratory Hematology | 2010 |
Expression of Cell-Cycle-Regulating Genes in the Development of Atherosclerosis in Japanese Quail (Coturnix japonica)
M Inafuku, T Toda, T Okabe, A Shinjo, H Iwasaki, H Oku |
Poultry science | 2007 |
Essentials of Restenosis
HJ Duckers, EG Nabel, PW Serruys |
2007 | |
The cell cycle: A critical therapeutic target to prevent vascular proliferative disease
T Charron, N Nili, BH Strauss |
Canadian Journal of Cardiology | 2006 |
Ursolic acid inhibits neointima formation in the rat carotid artery injury model
M Pozo, V Castilla, C Gutierrez, R Nicolás, J Egido, J González-Cabrero |
Atherosclerosis | 2006 |
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease
T Charron, N Nili, BH Strauss |
The Canadian journal of cardiology | 2006 |
Antisense therapy for restenosis following percutaneous coronary intervention
N Kipshidze, M Tsapenko, P Iversen, D Burger |
Expert Opinion on Biological Therapy | 2005 |
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy
E Huarte, I Tirapu, A Arina, M Vera, C Alfaro, O Murillo, B Palencia, V Busto, V Marín, G Mazzolini, I Melero |
Expert Opinion on Biological Therapy | 2005 |
Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems
CA Kavanagh, YA Rochev, WM Gallagher, KA Dawson, AK Keenan |
Pharmacology & Therapeutics | 2004 |
Polymeric sustained local drug delivery system for the prevention of vascular intimal hyperplasia
D Kanjickal, S Lopina, MM Evancho-Chapman, S Schmidt, D Donovan, S Springhetti |
Journal of Biomedical Materials Research | 2004 |
Thérapie génique des resténoses et de l'athérosclérose : espoirs et réalités
M Mazighi, D Tchétché, F Hyafil, LJ Feldman |
Pathologie Biologie | 2004 |
Regulation of vascular smooth muscle cell growth: targeting the final common pathway
AM Taylor, CA McNamara |
Arteriosclerosis, thrombosis, and vascular biology | 2003 |
Gene Therapy for Cardiovascular Disease
KL Dishart, LM Work, L Denby, AH Baker |
Journal of Biomedicine and Biotechnology | 2003 |
Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation
Kasturi Ranganna, Zivar Yousefipour, Frank M Yatsu, Shirlette G Milton, Barbara E Hayes |
Molecular and Cellular Biochemistry | 2003 |
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
VJ Dzau, RC Braun-Dullaeus, DG Sedding |
Nature Medicine | 2002 |
Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering
CA Thompson, SN Oesterle |
Vascular medicine (London, England) | 2002 |
Spatial repression of PCNA by p53 during kidney development
Z Saifudeen, J Marks, H Du, SS El-Dahr |
American journal of physiology. Renal physiology | 2002 |
c-Jun Regulates Vascular Smooth Muscle Cell Growth and Neointima Formation after Arterial Injury: INHIBITION BY A NOVEL DNA ENZYME TARGETING c-Jun
LM Khachigian, RG Fahmy, G Zhang, YV Bobryshev, A Kaniaros |
The Journal of biological chemistry | 2002 |
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin
RC Braun-Dullaeus, MJ Mann, U Seay, L Zhang, HE von der Leyen, RE Morris, VJ Dzau |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries
DA Tulis, W Durante, KJ Peyton, AJ Evans, AI Schafer |
Atherosclerosis | 2001 |
Gene therapy in heart disease
E Teiger, I Deprez, V Fataccioli, S Champagne, J Duboisrande, M Eloit, S Adnot |
Biomedecine & Pharmacotherapy | 2001 |
Localized adenovirus gene delivery using antiviral IgG complexation
RJ Levy, C Song, S Tallapragada, S DeFelice, JT Hinson, N Vyavahare, J Connolly, K Ryan, Q Li |
Gene Therapy | 2001 |
The Influence of Arm Length Asymmetry and Base Substitution on the Activity of the 10-23 DNA Enzyme
MJ Cairns, TM Hopkins, C Witherington, LQ Sun |
Antisense and Nucleic Acid Drug Development | 2000 |
Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery
T Mori, J Durand, YF Chen, JA Thompson, S Bakir, S Oparil |
The American Journal of Cardiology | 2000 |
Gene therapy for hypertension and restenosis
M Gardon, MK Raizada, MJ Katovich, KH Berecek, CH Gelband |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
Antisense and gene therapy to prevent restenosis
A Ehsan, MJ Mann |
Vascular medicine (London, England) | 2000 |
Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells
K Ranganna, F M Yatsu, B E Hayes, S G Milton, A Jayakumar |
Molecular and Cellular Biochemistry | 2000 |
Transgenic and therapeutic targeting of smooth muscle cells and the challenges presented by phenotypic diversity
AR Strauch, JG Cogan, RJ Kelm, SV Subramanian, MJ Getz |
Expert Opinion on Therapeutic Targets | 1999 |
Antisense Strategies to Inhibit Restenosis
M Lee, AD Simon, C Stein, LE Rabbani |
Antisense and Nucleic Acid Drug Development | 1999 |
New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
FS Santiago, HC Lowe, MM Kavurma, CN Chesterman, A Baker, DG Atkins, LM Khachigian |
Nature Medicine | 1999 |
Suppression of Smooth Muscle Cell Proliferation by a c- myc RNA-cleaving Deoxyribozyme
LQ Sun, MJ Cairns, WL Gerlach, C Witherington, L Wang, A King |
The Journal of biological chemistry | 1999 |
Target site selection for an RNA-cleaving catalytic DNA
MJ Cairns, TM Hopkins, C Witherington, L Wang, LQ Sun |
Nature Biotechnology | 1999 |
Hormones and Vasoprotection
S Oparil |
Hypertension | 1999 |
Chimeric DNA-RNA Hammerhead Ribozyme to Proliferating Cell Nuclear Antigen Reduces Stent-Induced Stenosis in a Porcine Coronary Model
A Frimerman, PJ Welch, X Jin, N Eigler, S Yei, J Forrester, H Honda, R Makkar, J Barber, F Litvack |
Circulation | 1999 |
Applications of Antisense Therapies to Restenosis
LR Rabbani |
1999 | |
Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein
SJ George, JL Johnson, GD Angelini, AC Newby, AH Baker |
Human Gene Therapy | 1998 |
Cell cycle progression: new therapeutic target for vascular proliferative disease
RC Braun-Dullaeus, MJ Mann, VJ Dzau |
Circulation | 1998 |
Locally Applied Antisense Oligonucleotide to Proliferating Cell Nuclear Antigen Inhibits Intimal Thickening in Experimental Vein Grafts
GJ Fulton, MG Davies, L Barber, E Svendsen, PO Hagen |
Annals of Vascular Surgery | 1998 |
Frontiers in Interventional Cardiology
EJ Topol, PW Serruys |
Circulation | 1998 |
Antisense Research and Application
ST Crooke |
1998 | |
Inhibition of Growth of Human Vascular Smooth Muscle Cells by Overexpression of p21 Gene Through Induction of Apoptosis
H Matsushita, R Morishita, I Kida, M Aoki, S Hayashi, N Tomita, K Yamamoto, A Moriguchi, A Noda, Y Kaneda, J Higaki, T Ogihara |
Hypertension | 1998 |
Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
RL Wilensky |
1998 | |
Herz-Kreislauf-Erkrankungen
D Ganten, K Ruckpaul |
1998 | |
Attenuation of Calcitonin Gene Expression in Pregnant Rat Uterus Leads to a Block in Embryonic Implantation*
LJ Zhu, MK Bagchi, IC Bagchi |
Endocrinology | 1998 |
Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis
Rabbani, Wang |
Journal of Thrombosis and Thrombolysis | 1998 |
Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis
G Golomb, I Fishbein |
Advanced Drug Delivery Reviews | 1997 |
Gene-based therapies for restenosis
V Labhasetwar, B Chen, DW Muller, J Bonadio, K Ciftci, K March, RJ Levy |
Advanced Drug Delivery Reviews | 1997 |
Nanoparticle drug delivery system for restenosis
V Labhasetwar, C Song, RJ Levy |
Advanced Drug Delivery Reviews | 1997 |
Local delivery of c-myb antisense oligonucleotides during balloon angioplasty
MA Azrin, JF Mitchel, LM Bow, CA Pedersen, RW Cartun, TH Aretz, DD Waters, RG McKay |
Catheterization and Cardiovascular Diagnosis | 1997 |
Tranilast inhibits contraction of rat aortic smooth muscle
T Ihara, U Ikeda, S Ishibashi, K Shimada |
European Journal of Pharmacology | 1997 |
Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts
R Brauner, H Laks, DC Drinkwater, G Chaudhuri, O Shvarts, T Drake, S Bhuta, D Mishaly, I Fishbein, G Golomb |
The Journal of Thoracic and Cardiovascular Surgery | 1997 |
Site-specific delivery of colchicine in rat carotid artery model of restenosis
D Mishaly, I Fishbein, D Moscovitz, G Golomb |
Journal of Controlled Release | 1997 |
Gene Transfer in the Cardiovascular System
KL March |
1997 | |
Antisense Oligonucleotide Inhibition of PDGFR-β Receptor Subunit Expression Directs Suppression of Intimal Thickening
MG Sirois, M Simons, ER Edelman |
Circulation | 1997 |
Impact of Molecular Biology and New Technical Developments in Diagnostic Imaging
W Semmler, M Schwaiger |
1997 | |
Novel Methods in Molecular and Cellular Biochemistry of Muscle
GN Pierce, WC Claycomb |
1997 | |
DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors
P D'Orléans-Juste, M G Sirois, E R Edelman, D Regoli, L H Pheng, G Bkaily, C J Lindsey |
Molecular and Cellular Biochemistry | 1997 |
Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries
RD Simari, H San, M Rekhter, T Ohno, D Gordon, GJ Nabel, EG Nabel |
Journal of Clinical Investigation | 1996 |
Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides
W Wang, HJ Chen, A Schwartz, PJ Cannon, CA Stein, LE Rabbani |
Journal of Clinical Investigation | 1996 |
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
R E Law, W P Meehan, X P Xi, K Graf, D A Wuthrich, W Coats, D Faxon, W A Hsueh |
Journal of Clinical Investigation | 1996 |
Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries
K Uchida, M Sasahara, N Morigami, F Hazama, M Kinoshita |
Atherosclerosis | 1996 |
Vascular access stenosis: Prospects for prevention and therapy
VP Sukhatme |
Kidney International | 1996 |
Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model
G Golomb, I Fishbein, S Banai, D Mishaly, D Moscovitz, SD Gertz, A Gazit, E Poradosu, A Levitzki |
Atherosclerosis | 1996 |
Cardiovascular Gene Therapy: Current Concepts
JC Fox |
Therapeutic Drug Monitoring | 1996 |
Antisense Approach to Restenosis
M Simons |
Japanese Circulation Journal | 1996 |
…and surreal antisense?
M Simons, RD Rosenberg, ER Edelman |
Nature Medicine | 1996 |
Reply to “…and surreal antisense?”
CA Stein |
Nature Medicine | 1996 |
Therapeutic manipulation of cell cycle in smooth muscle cells: Implications for restenosis
M Simons |
Journal of Laboratory and Clinical Medicine | 1996 |
Prevention of Restenosis by Local Drug Delivery
RR Makkar, N Eigler, F Litvack, JS Forrester |
Journal of cardiovascular pharmacology and therapeutics | 1996 |
Processing of Chimeric Antisense Oligonucleotides by Human Vascular Smooth Muscle Cells and Human Atherosclerotic Plaque: Implications for Antisense Therapy of Restenosis After Angioplasty
JG Pickering, JM Isner, CM Ford, L Weir, A Lazarovits, EF Rocnik, LH Chow |
Circulation | 1996 |
Tranilast Suppresses Intimal Hyperplasia in the Balloon Injury Model and Cuff Treatment Model in Rabbits
J Fukuyama, K Ichikawa, K Miyazawa, S Hamano, N Shibata, A Ujiie |
The Japanese Journal of Pharmacology | 1996 |
Gene therapy for vascular diseases
EG Nabel |
Atherosclerosis | 1995 |
Potential of Antisense Technology in the Treatment of Immunological Disorders
AM Krieg, AD Steinberg |
Clinical immunotherapeutics | 1995 |
The Intima: Soil for Atherosclerosis and Restenosis
SM Schwartz, D deBlois, ER OBrien |
Circulation research | 1995 |
Effects of Antisense c- myb Oligonucleotides on Vascular Smooth Muscle Cell Proliferation and Response to Vessel Wall Injury
AE Villa, LA Guzman, EJ Poptic, V Labhasetwar, S DSouza, CL Farrell, EF Plow, RJ Levy, PE DiCorleto, EJ Topol |
Circulation research | 1995 |
c- myc in Vasculoproliferative Disease
ER Edelman, M Simons, MG Sirois, RD Rosenberg |
Circulation research | 1995 |
Interventionen am Herzen
F Unger, H Mörl, HA Dieterich |
1995 | |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |
Gene inhibition using antisense oligodeoxynucleotides
RW Wagner |
Nature | 1994 |
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
T Ohno, D Gordon, H San, VJ Pompili, MJ Imperiale, GJ Nabel, EG Nabel |
Science | 1994 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |